MEDICLIN Aktiengesellschaft (ETR:MED)
Germany · Delayed Price · Currency is EUR | Market Cap | 189.05M |
| Revenue (ttm) | 793.91M |
| Net Income (ttm) | 35.05M |
| Shares Out | 47.50M |
| EPS (ttm) | 0.74 |
| PE Ratio | 5.39 |
| Forward PE | 5.45 |
| Dividend | 0.04 (1.01%) |
| Ex-Dividend Date | n/a |
| Volume | 19,045 |
| Average Volume | 5,634 |
| Open | 3.980 |
| Previous Close | 3.920 |
| Day's Range | 3.980 - 4.060 |
| 52-Week Range | 2.800 - 4.060 |
| Beta | 0.31 |
| RSI | 65.45 |
| Earnings Date | Mar 27, 2026 |
About ETR:MED
MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute, Acute, and Other Activities segments. It offers medical services in the areas of neurology, psychosomatics, orthopedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, vascular medicine, otorhinolaryngology, cardiac medicine, rheumatology, pain medicine, trauma surgery, urology, and others. The company also provides services in the areas of ENT and acute outpatient services. It owns clinics, rehabilitation care, nursing care fac... [Read more]
Financial Performance
Financial StatementsNews
EQS-AFR: MEDICLIN AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements
EQS Preliminary announcement financial reports: MEDICLIN AG / Preliminary announcement on the disclosure of financial statements MEDICLIN AG: Preliminary announcement of the publication of quarterly r...
EQS-AFR: MEDICLIN AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQS Preliminary announcement financial reports: MEDICLIN AG / Preliminary announcement on the disclosure of financial statements MEDICLIN AG: Preliminary announcement of the publication of financial r...
MEDICLIN: Thriving Business Growth Exceeds Expectations
MEDICLIN's financial performance in the first nine months of 2025 showcases resilience and growth. With a notable 5.1% increase in sales and a significant rise in operating results, the company has de...
EQS-News: MEDICLIN on track: business development in line with expectations
EQS-News: MEDICLIN AG / Key word(s): 9 Month figures/Miscellaneous MEDICLIN on track: business development in line with expectations 04.11.2025 / 14:13 CET/CEST The issuer is solely responsible for th...
MEDICLIN AG: Shareholders Back All AGM Resolutions!
In a landmark virtual gathering, MEDICLIN AG celebrated a record-breaking year at its Annual General Meeting on June 4, 2025. With unanimous support for all resolutions, the company is poised to revol...
EQS-News: MEDICLIN AG: Annual General Meeting approves all proposed resolutions
EQS-News: MEDICLIN AG / Key word(s): AGM/EGM MEDICLIN AG: Annual General Meeting approves all proposed resolutions 04.06.2025 / 13:27 CET/CEST The issuer is solely responsible for the content of this ...
MEDICLIN Celebrates a Successful 2024 Financial Year
In 2024, MEDICLIN AG reached unprecedented financial success, with sales hitting EUR 748.8 million and an operating result of EUR 53.5 million, thanks to strategic growth and key acquisitions. Jetzt d...
EQS-News: MEDICLIN ends successful 2024 financial year
EQS-News: MEDICLIN AG / Key word(s): Annual Report/Miscellaneous MEDICLIN ends successful 2024 financial year 28.03.2025 / 10:24 CET/CEST The issuer is solely responsible for the content of this annou...
EQS-News: MEDICLIN invites you to the 2025 virtual press conference on the financial statements for the year 2024
EQS-News: MEDICLIN AG / Key word(s): Conference/Miscellaneous MEDICLIN invites you to the 2025 virtual press conference on the financial statements for the year 2024 19.03.2025 / 15:18 CET/CEST The is...
MEDICLIN Unveils 2024 Financial Year Preliminary Figures
MEDICLIN's 2024 performance reflects strategic growth, with sales rising to EUR 748.8 million and operating results soaring. The company excelled in post-acute care, while strategic investments set th...
EQS-News: MEDICLIN presents preliminary figures for the 2024 financial year
EQS-News: MEDICLIN AG / Key word(s): Preliminary Results MEDICLIN presents preliminary figures for the 2024 financial year 27.02.2025 / 13:03 CET/CEST The issuer is solely responsible for the content ...
MEDICLIN Boosts 2024 Outlook with Raised Guidance
MEDICLIN AG anticipates a prosperous 2024, raising its EBIT forecast to EUR 48-54 million and predicting sales growth of 1-3%, with detailed results due in February 2025. Jetzt den vollständigen Artik...
EQS-Adhoc: MEDICLIN raises full-year guidance for the 2024 financial year
EQS-Ad-hoc: MEDICLIN AG / Key word(s): Forecast/Annual Results MEDICLIN raises full-year guidance for the 2024 financial year 21-Jan-2025 / 16:36 CET/CEST Disclosure of an inside information acc. to A...
MEDICLIN Boosts Sales & Profits; 2024 Forecast Confirmed by Management
MEDICLIN has shown robust growth in 2024, with sales climbing by 2.0% and EBIT rising significantly. As the company enhances its services and anticipates hospital reforms, it remains optimistic about ...
EQS-News: MEDICLIN increases consolidated sales and operating result - Management Board confirms annual forecast for 2024
EQS-News: MEDICLIN AG / Key word(s): 9 Month figures/Miscellaneous MEDICLIN increases consolidated sales and operating result - Management Board confirms annual forecast for 2024 04.11.2024 / 14:30 CE...